Log on / register
Feedback | Support | My details
Interleukin-6: a new therapeutic target.
Smolen JS, Maini RN
Arthritis Res Ther 2006, 8 Suppl 2:S5
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.




Research article
In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage
Pretzel D, Pohlers D, Weinert S, Kinne RW
Arthritis Research & Therapy 2009, 11:R25 (18 February 2009)
[Full text] [PubMed Central] [PubMed] [Related articles] [F1000 Medicine]
2.


Research article
Therapeutic effects of antibodies to tumor necrosis factor-, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis
Matsumoto I, Zhang H, Yasukochi T, Iwanami K, Tanaka Y, Inoue A, Goto D, Ito S, Tsutsumi A, Sumida T
Arthritis Research & Therapy 2008, 10:R66 (5 June 2008)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]
3.


Review
Cells of the synovium in rheumatoid arthritis. Macrophages
Kinne RW, Stuhlmüller B, Burmester GR
Arthritis Research & Therapy 2007, 9:224 (21 December 2007)
[Full text] [PubMed Central] [PubMed] [Related articles] [Cited on BioMed Central]
4.


Correction
Correction: Interleukin-6: a new therapeutic target
Smolen JS, Maini RN
Arthritis Research & Therapy 2006, 8:407 (17 October 2006)

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.